AKT1 and Miyoshi myopathy: KIT mutations are activators of both the MAPK and PI3K (Phosphoinositide 3-kinase)/AKT (protein kinase B) pathways and are more frequent in AM and MM than in CM, where the frequency is 5-10% (5, 20–22).